lasmiditan
Selected indexed studies
- Lasmiditan for acute treatment of migraine. (Drugs Today (Barc), 2021) [PMID:33656015]
- Lasmiditan. (, 2012) [PMID:34324283]
- Lasmiditan. (, 2006) [PMID:33104315]
_Worker-drafted node — pending editorial review._
Connections
lasmiditan is a side effect of
Sources
- Lasmiditan for acute treatment of migraine. (2021) pubmed
- Lasmiditan. (2012) pubmed
- Lasmiditan. (2006) pubmed
- The potential of lasmiditan in migraine. (2020) pubmed
- Lasmiditan for the acute treatment of migraine. (2021) pubmed
- Efficacy of lasmiditan, rimegepant and ubrogepant for acute treatment of migraine in triptan insufficient responders: systematic review and network meta-analysis. (2024) pubmed
- Lasmiditan: Acute Migraine Treatment Without Vasoconstriction. A Review. (2021) pubmed
- Lasmiditan: First Approval. (2019) pubmed
- Lasmiditan for Acute Treatment of Migraine in Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials. (2020) pubmed
- Profiling lasmiditan as a treatment option for migraine. (2020) pubmed